GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pangen Biotech Inc (XKRX:222110) » Definitions » Shiller PE Ratio

Pangen Biotech (XKRX:222110) Shiller PE Ratio : (As of May. 13, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Pangen Biotech Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Pangen Biotech Shiller PE Ratio Historical Data

The historical data trend for Pangen Biotech's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pangen Biotech Shiller PE Ratio Chart

Pangen Biotech Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Pangen Biotech Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Pangen Biotech's Shiller PE Ratio

For the Biotechnology subindustry, Pangen Biotech's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pangen Biotech's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pangen Biotech's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Pangen Biotech's Shiller PE Ratio falls into.


;
;

Pangen Biotech Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Pangen Biotech's E10 for the quarter that ended in Dec. 2024 is calculated as:

For example, Pangen Biotech's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-48/121.1352*121.1352
=-48.000

Current CPI (Dec. 2024) = 121.1352.

Pangen Biotech Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201503 -228.000 99.721 -276.962
201506 -136.000 100.051 -164.660
201509 -51.000 100.111 -61.711
201512 -33.000 100.220 -39.887
201603 -240.000 100.561 -289.103
201606 -90.000 100.791 -108.166
201609 -217.000 101.461 -259.078
201612 -82.000 101.561 -97.804
201703 -115.000 102.851 -135.444
201706 -85.000 102.611 -100.345
201709 -71.000 103.491 -83.105
201712 -474.000 102.991 -557.507
201803 -146.000 104.101 -169.891
201806 18.000 104.130 20.939
201809 -18.000 105.651 -20.638
201812 -335.000 104.351 -388.884
201903 -172.000 104.491 -199.398
201906 -219.000 104.881 -252.940
201909 -181.000 105.200 -208.416
201912 -355.000 105.121 -409.080
202003 -127.000 105.354 -146.023
202006 -72.000 105.112 -82.976
202009 -158.000 106.198 -180.224
202012 -95.000 105.765 -108.805
202103 -217.000 107.357 -244.849
202106 -4.000 107.579 -4.504
202109 -39.000 108.759 -43.438
202112 -70.000 109.676 -77.313
202203 -84.000 111.848 -90.975
202206 -207.000 114.072 -219.817
202209 -93.000 114.715 -98.205
202212 -37.000 115.179 -38.913
202303 -121.000 116.507 -125.806
202306 -32.000 117.182 -33.080
202309 -93.000 118.964 -94.698
202312 -192.000 118.837 -195.713
202403 6.000 120.123 6.051
202406 -1.000 120.007 -1.009
202409 104.000 120.861 104.236
202412 -48.000 121.135 -48.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Pangen Biotech  (XKRX:222110) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Pangen Biotech Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Pangen Biotech's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pangen Biotech Business Description

Traded in Other Exchanges
N/A
Address
4Floor Innoplex 2-dong, 306 Sinwon-ro, Yeongtong-gu, Gyeonggi-do, Suwon-si, KOR, 16675
Pangen Biotech Inc is a biotechnology company. It is engaged in development of biosimilar products and technology transfer services for biologics development. It develops biosimilar products, such as EPO, recombinant factor VIII, G-CSF, etc.

Pangen Biotech Headlines

No Headlines